CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-30 | Turner Kathy V Senior Vice President | Exercise or conversion | +2,250 | $79.54 | $179K | 5,125.39 |
| 2021-08-30 | Turner Kathy V Senior Vice President | Sale | −1,000 | $685.00 | $685K | 4,125.39 |
| 2021-08-30 | Turner Kathy V Senior Vice President | Sale | −1,250 | $689.00 | $861K | 2,875.39 |
| 2021-08-30 | Turner Kathy V Senior Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −2,250 | 7,736 | ||
| 2021-08-27 | Turner Kathy V Senior Vice President | Exercise or conversion | +276 | $64.24 | $18K | 3,151.39 |
| 2021-08-27 | Turner Kathy V Senior Vice President | Sale | −276 | $678.00 | $187K | 2,875.39 |
| 2021-08-27 | Turner Kathy V Senior Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −276 | 0 | ||
| 2021-08-23 | POLEWACZYK JAMES F Executive Vice President | Gift | −522 | 19,494.28 | ||
| 2021-08-16 | MAZELSKY JONATHAN JAY President & CEO | Sale | −533 | $672.36 | $358K | 50,156.64 |
| 2021-08-16 | MAZELSKY JONATHAN JAY President & CEO | Sale | −488 | $673.69 | $329K | 49,668.64 |
| 2021-08-16 | MAZELSKY JONATHAN JAY President & CEO | Sale | −182 | $674.48 | $123K | 49,486.64 |
| 2021-08-16 | MAZELSKY JONATHAN JAY President & CEO | Sale | −60 | $675.44 | $41K | 49,426.64 |
| 2021-08-13 | MAZELSKY JONATHAN JAY President & CEO | Sale | −3,417 | $675.34 | $2.3M | 52,009.64 |
| 2021-08-13 | MAZELSKY JONATHAN JAY President & CEO | Sale | −983 | $676.38 | $665K | 51,026.64 |
| 2021-08-13 | MAZELSKY JONATHAN JAY President & CEO | Sale | −337 | $677.58 | $228K | 50,689.64 |
| 2021-08-10 | JUNIUS DANIEL M Director | Exercise or conversion | +2,402 | $85.00 | $204K | 5,298 |
| 2021-08-10 | JUNIUS DANIEL M Director | Sale | −2,402 | $679.58 | $1.6M | 2,896 |
| 2021-08-10 | JUNIUS DANIEL M Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −2,402 | 0 | ||
| 2021-08-10 | Hunt Nimrata Executive Vice President | Exercise or conversion | +769 | $67.85 | $52K | 8,875.28 |
| 2021-08-10 | Hunt Nimrata Executive Vice President | Exercise or conversion | +337 | $141.60 | $48K | 9,212.28 |
Page 65 of 74 · 1,474 trades